Related Experiment Video
Updated: Jun 23, 2026

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images
Published on: September 7, 2017
Modulation of the activity of methyl binding domain protein 4 (MBD4/MED1) while processing iododeoxyuridine generated
Mohammad Azhar Aziz1, Jane E Schupp, Timothy J Kinsella
1Department of Radiation Oncology, University Hospitals Case Medical Center and the Case Integrative Cancer Biology Program, Case Western Reserve University, Cleveland, OH, USA.
Abstract:
DNA glycosylases function to remove endogenous and exogenous base damage and thus contribute to the maintenance of genomic integrity. This function gains clinical relevance when base mispairs introduced by chemotherapy or radiosensitizing drugs become their substrate. This report describes the action of DNA glycosylases on the mispairs generated by iododeoxyuridine (IUdR)-a radiosensitizer. A non-radioactive fluorescent dye-based in vitro glycosylase assay was employed to quantitatively measure the enzymatic activities of functionally related DNA glycosylases on IUdR generated mispairs including G:IU and A:IU. Thymine DNA glycosylase (TDG) and methyl binding domain protein 4 (MBD4/MED1) are found to act on G:IU (but not A:IU) mispairs and are functionally complementary to each other. However, uracil DNA glycosylase (UDG) does not show any activity on these mispairs. The methyl binding domain of MBD4/MED1 was found to specifically inhibit the activity of MBD4/MED1 as well as the glycosylase domain, when the G:IU mispairs were located in a methylated CpG context. However, inhibition of TDG activity on methylated G:IU mispairs by the methyl binding domain was not observed.
Insights
DNA glycosylases, including thymine DNA glycosylase (TDG) and methyl binding domain protein 4 (MBD4/MED1), repair chemotherapy-induced DNA damage. These enzymes specifically target G:IU mispairs, crucial for maintaining genomic integrity.
Area of Science:
- Molecular Biology
- Genomics
- Biochemistry
Background:
- DNA glycosylases are critical for genomic integrity, removing damaged DNA bases.
- Chemotherapy and radiosensitizing drugs can introduce DNA base mispairs, creating a substrate for DNA glycosylases.
- Iododeoxyuridine (IUdR) is a radiosensitizer that generates specific DNA mispairs.
Purpose of the Study:
- To investigate the enzymatic activity of DNA glycosylases on mispairs generated by the radiosensitizer iododeoxyuridine (IUdR).
- To characterize the substrate specificity of thymine DNA glycosylase (TDG), methyl binding domain protein 4 (MBD4/MED1), and uracil DNA glycosylase (UDG) towards IUdR-induced mispairs.
- To determine the influence of DNA methylation on the activity of MBD4/MED1 and TDG on G:IU mispairs.
Main Methods:
- Utilized a non-radioactive fluorescent dye-based in vitro glycosylase assay.
- Quantitatively measured enzymatic activities of DNA glycosylases on G:IU and A:IU mispairs.
- Assessed the impact of methylated CpG contexts on enzyme activity.
Main Results:
- Thymine DNA glycosylase (TDG) and MBD4/MED1 demonstrated activity on G:IU mispairs but not A:IU mispairs.
- UDG showed no activity on the tested IUdR-generated mispairs.
- The methyl binding domain of MBD4/MED1 inhibited its own activity and glycosylase domain activity on G:IU mispairs within methylated CpG sites, but did not inhibit TDG.
Conclusions:
- TDG and MBD4/MED1 are functionally complementary in repairing G:IU mispairs, contributing to genomic stability.
- DNA methylation can modulate MBD4/MED1 activity on G:IU mispairs, highlighting context-dependent repair mechanisms.
- UDG is not involved in the repair of IUdR-induced G:IU or A:IU mispairs.
Related Concept Videos
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair
Mismatch Repair
Spontaneous and Induced Mutations
Abnormal Proliferation
Proofreading

